Syros Pharmaceuticals, Inc. (30) | Business Finance (12)
Browse by Subcategory
Recent Contracts
-
Form of Nonstatutory Stock Option Agreement for Inducement Awards
(Filed With SEC on October 13, 2021)
-
Underwriting Agreement, dated January 19, 2021, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several...
(Filed With SEC on January 20, 2021)
-
Form of Warrant to Purchase Common Stock or Pre-Funded Warrants
(Filed With SEC on December 7, 2020)
-
Asset Purchase Agreement, dated as of December 4, 2020, by and between Syros Pharmaceuticals, Inc. and Orsenix, LLC
(Filed With SEC on December 7, 2020)
-
Registration Rights Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto
(Filed With SEC on December 7, 2020)
-
Loan and Security Agreement, dated February 12, 2020, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender
(Filed With SEC on February 13, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 7, 2020)
-
Securities Purchase Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto
(Filed With SEC on December 7, 2020)
-
Underwriting Agreement relating to the Common Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as...
(Filed With SEC on April 8, 2019)
-
Underwriting Agreement relating to the Preferred Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as...
(Filed With SEC on April 8, 2019)
-
Form of Class A Warrant
(Filed With SEC on April 8, 2019)
-
Form of Series A Convertible Preferred Stock Certificate
(Filed With SEC on April 8, 2019)